Flotetuzumab (FLZ), an Investigational CD123 x CD3 Bispecific Dart® Protein-Induced Clustering of CD3+ T Cells and CD123+ AML Cells in Bone Marrow Biopsies Is Associated with Response to Treatment in Primary Refractory AML Patients
暂无分享,去创建一个
B. Fox | J. Wigginton | C. Bifulco | T. Moudgil | S. Jensen | C. Ballesteros-Merino | J. Davidson-Moncada | J. Muth | J. Godwin | Nikhil Lonberg